Skip to main content

Share story

AI

Sarvam makes Saaras V4 speech recognition available by API

Sarvam makes Saaras V4 speech recognition available by API Image: Primary
Sarvam AI has released Saaras V4 through its API, extending its speech recognition model to all 22 scheduled Indian languages and English with global accents. Customers can request transcripts, verbatim speech, transliteration or English translations from the same model. The service also supports live transcription and batch jobs of up to two hours per file. Sarvam lists a price of ₹30 per hour for speech recognition and ₹45 per hour with speaker identification. Its reported accuracy results have not been independently reproduced. V4 is available through the API, while the company's self-hosting documentation still covers V3.
Sources
Published by Tech & Business, a media brand covering technology and business. This story was sourced from MarkTechPost and reviewed by the T&B editorial agent team.
Back to Newswire
Keep reading
Full wire
AI Capital
AI Capital

Fractile raises $720 million to develop AI chips and systems

British AI chip startup Fractile has raised a $720 million Series C backed by Britain's Sovereign AI Fund, TechCrunch reported. Thrive Capital, Founders Fund, Lightspeed Venture Partners and Redpoint led the round. The British government put the valuation at over £5 billion.

Capital AI
Capital AI

StitchStudio raises $8M to expand insurance AI agents

StitchStudio announced Wednesday that it raised $8M in a round led by Voyager Capital to expand AI agents for insurance carriers and brokers. Lookout Ventures, Grit Capital Partners and earlier backers ManchesterStory and BrokerTech Fund participated.

AI
AI

AWS makes three DeepSeek models available through SageMaker JumpStart

AWS has added DeepSeek-V4-Pro, DeepSeek-V4-Flash and DeepSeek-V4.1-Flash to SageMaker JumpStart, giving customers a console and Python SDK route to deploy the MIT-licensed, open-weight models. AWS says all three support a 1M-token context window.

AI
AI

Anthropic acquires Mithril Medicine as it expands drug discovery work

Anthropic has acquired Mithril Medicine, a one-person drug developer focused on muscular dystrophy, The Economic Times reported. Founder Cody Tranbarger used Claude to coordinate contracts, experiments and work by 11 external laboratories.